Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis

Comparative effects of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors on heart failure with preserved ejection fraction in diabetic patients: a meta-analysis

Abstract Background Heart failure with preserved ejection fraction (HFpEF) is common in type 2 diabetes mellitus (T2D), leading to high morbidity and mortality. Managing HFpEF in diabetic patients is challenging with limited treatments. Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Arif Albulushi, Desmond Boakye Tanoh, Ahmed Almustafa, Nadya Al Matrooshi, Ronald Zolty, Brian Lowes
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2024-08-01
Sarja:Cardiovascular Diabetology
Aiheet:
HFpEF
Type 2 diabetes mellitus
SGLT2 inhibitors
GLP1 receptor agonists
Cardiovascular outcomes
Linkit:https://doi.org/10.1186/s12933-024-02415-8

Internet

https://doi.org/10.1186/s12933-024-02415-8

Samankaltaisia teoksia